I thought Nemesis laid the case out pretty well. I saw no real replies to him on that specific post. He wrote:
"Does it not concern you that KCH, in 2015, after years of recruiting trial patients with ‘GBM4’, should make such a prognosticative error, because, if they were putting patients forward that had, in reality, a more than a fair chance of long term survival without the vaccine, do you not see how that patient selection could bias the results ? "
Market Data 
Markets 
AI
